Key result
Implementation of evidence-based heart failure therapies and resource allocation for emerging technologies remain major clinical challenges.
Highlights the challenge of implementing evidence-based therapies and allocating resources for emerging technologies in heart failure.
The publication of a large number of randomised controlled trials in heart failure patients over the last 25 years has allowed the development of several excellent evidence-based guidelines.1–3 Revised SIGN guidelines for heart failure are due for publication this year.3 The major challenge facing us now is the implementation of these evidence-based therapies and the allocation of resources to allow the development and assessment of emerging technologies to ensure that patients receive the treatments they need.
No takes yet. Share an insight, caveat, or question.
SJ Leslie (2006) conducted a review in Heart failure. Heart failure therapies was evaluated. Implementation of evidence-based heart failure therapies and resource allocation for emerging technologies remain major clinical challenges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: